Dumolas, Judy Ann .

HRN: 28-62-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2026
CEFUROXIME 500MG (TAB)
03/01/2026
03/07/2026
PO
500 Mg
BID
Thinly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: